Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT03285321 · COMPLETED
Trial details
- NCT number
- NCT03285321
- Sponsor
- Greg Durm, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-15
- Primary completion
- 2023-10-13
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.